$10M Pepcid Patent Verdict Nixed As Judge Reverses Herself
$10M Pepcid Patent Verdict Nixed As Judge Reverses Herself Law360 Full coverage
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Fed. Circ. Upholds Genzyme’s Win In Stem Cell Patent Case
Law360, New York (December 18, 2017, 7:04 PM EST) — The Federal Circuit on Monday affirmed a Delaware federal judge’s finding in a bench trial that a Genzyme Corp. patent on harvesting stem cells is valid, leaving in place a ruling that barred generic versions of the cancer drug Mobozil... Continue reading
-
In: PATENT NEWS
$10M Pepcid Patent Verdict Nixed As Judge Reverses Herself
Law360, New York (December 18, 2017, 7:02 PM EST) — Perrigo Co. has not infringed various aspects of a Boston hospital’s now-expired patent on the Pepcid Complete antacid, a Massachusetts federal judge said Friday, reversing the findings in three of her previous judgments and negating a $10.2 …
-
In: PATENT NEWS
Fed. Circ. Affirms 3rd PTAB Decision Upholding Acacia Patent
Law360, New York (December 18, 2017, 6:37 PM EST) — The Federal Circuit on Monday affirmed a Patent Trial and Appeal Board decision upholding the validity of a wireless communications patent that was challenged by HTC and ZTE, adding to a recent string of victories for an Acacia Research …
-
In: PATENT NEWS
Marathon Patent Group, Inc. Announces $7450000 Registered Direct Offering
Marathon Patent Group, Inc. Announces $7450000 Registered Direct Offering Nasdaq Full coverage
-
In: PATENT NEWS
Bolar Exemption in Europe and Asia
… in the national patent laws of many Asian countries. The scope of exemption varies significantly from state to state. For example, Pakistan provides Bolar-type provisions for research intended to be submitted to authorities in the country, while India more broadly exempts acts relating to the development …
-
In: PATENT NEWS
Bolar Exemptions in North America
Because approval by the U.S. Food and Drug Administration (FDA) is a long, sometimes arduous process, U.S. law provides a research or experimental use exemption with respect to regulated products. Congress enacted the Drug Price Competition and Patent Term Restoration Act of 1984 (the …
-
In: PATENT NEWS
USPTO Treats US, Foreign Applicants The Same, Study Says
Law360, New York (December 18, 2017, 5:31 PM EST) — A new study has found that patent applications from foreign companies are granted by the U.S. Patent and Trademark Office at about the same rate as those from companies headquartered in the U.S., despite challenges faced by foreign filers.
-
In: PATENT NEWS
THE LATEST: Non-Infringement of a Patent Also Not an Antitrust Injury
THE LATEST: Non-Infringement of a Patent Also Not an Antitrust Injury The National Law Review Full coverage
-
In: PATENT NEWS
THE LATEST: Non-Infringement of a Patent Also Not an Antitrust Injury
Cascades asserted that merely installing the Android mobile device operating system resulted in an infringement of this patent. In California, Cascades relied on antitrust law arguing the agreement between defendants not to purchase licenses amounted to a violation. Again, the ‘750 patent was …